Back to Top Skip to main content Skip to sub-navigation

Marines, Sailors with PHIBRON 11, 31st MEU receive COVID-19 vaccine

Military health personnel giving the COVID-19 Vaccine to military personnel Navy Hospital Corpsman 1st Class Javier Flores injects a COVID-19 vaccination to Navy Retail Specialist Seaman Jordan Davis aboard amphibious transport dock ship USS New Orleans. New Orleans, part of the America Expeditionary Strike Group, along with the 31st Marine Expeditionary Unit, is operating in the U.S. 7th Fleet area of responsibility (U.S. Navy photo by Petty Officer 2nd Class Kelby Sanders).

Recommended Content:

Coronavirus | Immunization Healthcare | COVID-19 Vaccine Efforts

In a critical move for readiness, resiliency and safety, ships of Amphibious Squadron (PHIBRON) 11 received their first dose of the Moderna COVID-19 vaccine last weekend in Okinawa, Japan.

The amphibious transport dock USS New Orleans, along with the amphibious dock landing ships USS Germantown and USS Ashland, in cooperation with U.S. Naval Hospital Okinawa and the embarked 31st Marine Expeditionary Unit, rolled up their sleeves for their first dose of the vaccine.

“As the premier crisis response force in the Indo-Pacific, we have to be ready to respond to the region’s needs at a moment’s notice,” said Navy Capt. Richard LeBron, PHIBRON 11 commodore. “The better protected we are against the coronavirus, the greater assurance I can give our fleet commanders that our ships, Sailors and Marines are without a doubt always here and always ready to fight and deliver when called upon.

“Doing our part to help sink COVID is a huge step for these three ships as they continue to operate throughout the AOR, execute complex and challenging missions, and interact with our allies and partners,” said LeBron.

Vaccination for service members is voluntary, as vaccines are currently authorized for emergency use. Aboard New Orleans, the vast majority of the crew chose to receive the shot.

“The New Orleans crew has shown exceptional resilience in facing COVID-19 over the past year,” said Navy Capt. Brian Schrum, the ship’s commanding officer. “This vaccine will keep our Sailors safe, ready, and confident in our ability to operate forward and overcome any challenges we may encounter.”

Germantown, which recently celebrated the 35th anniversary of the ship’s commissioning, also saw the majority of the crew elect to get the vaccine.

“Following a concerted educational campaign led by our medical team, most of the crew chose to receive the vaccine,” said Navy Cmdr. Cullen Greenfield, Germantown’s commanding officer. “The pandemic has brought many trials, but the Germantown and her crew are resilient, flexible, and creative in meeting those challenges – we expect the vaccine will improve our ability to remain a ready force, stay healthy and operational, and sink COVID.”

According to the Center for Disease Control and Prevention, those receiving the Moderna vaccine should receive the second dose 28 days after the first dose.

“Once a Sailor or Marine is fully vaccinated with both their first and second dose of the Moderna vaccine, they should expect over ninety-four percent efficacy in preventing disease from COVID-19, which will virtually eliminate the risk of severe disease or death during an outbreak at sea,” said Navy Cmdr. Hamilton Tilley, Expeditionary Strike Group 7’s task force surgeon. “Receiving just the first vaccine dose gives significant protection and is the first step in not only protecting themselves but their family as well as fellow Sailors and Marines.”

Amphibious Squadron 11, the Navy’s only forward-deployed amphibious squadron, along with embarked Marines from the 31st Marine Expeditionary Unit, is operating in the U.S. 7th Fleet area of responsibility to enhance interoperability with allies and partners, and serve as a ready response force to defend peace and stability in the Indo-Pacific region.

You also may be interested in...

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2019

Report
2/8/2019

The 2019 child and adolescent immunization schedule summarizes the recommendations of the Advisory Committee on Immunization Practices (ACIP), including several changes from the 2018 immunization schedule.

Recommended Content:

Immunization Healthcare | Vaccine-Preventable Diseases | Vaccine Schedules

Global Routine Vaccination Coverage — 2017

Report
11/16/2018

Global coverage with vaccines to prevent diphtheria, tetanus, pertussis, polio, and measles has remained at 84%–85% since 2010. Prioritizing countries with the highest number of unvaccinated children to implement context-specific strategies has the potential to increase immunization coverage globally.

Recommended Content:

Immunization Healthcare | Measles-Mumps-Rubella | Polio | Tetanus-Diphtheria-Pertussis

Updated Framework for Development of Evidence-Based Recommendations by the Advisory Committee on Immunization Practices

Report
11/16/2018

In 2010, the Advisory Committee on Immunization Practices (ACIP) implemented the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach for developing evidence-based recommendations. Since its February 2018 meeting, ACIP has incorporated the use of Evidence to Decision or Evidence to Recommendation (EtR) frameworks into GRADE methodology.

Recommended Content:

Immunization Healthcare | Vaccine Recommendations

Vaccination Coverage Among Children Aged 19–35 Months — United States, 2017

Report
10/12/2018

The Advisory Committee on Immunization Practices recommends routine vaccination by age 24 months against 14 potentially serious illnesses. In 2017, coverage with most recommended vaccines among children aged 19–35 months remained stable and high but was lower in more rural areas and among uninsured or Medicaid-insured children.

Recommended Content:

Immunization Healthcare | Vaccine-Preventable Diseases | Vaccine Schedules

Vaccination Coverage for Selected Vaccines and Exemption Rates Among Children in Kindergarten — United States, 2017–18 School Year

Report
10/12/2018

Immunization programs conduct annual kindergarten vaccination assessments to monitor school-entry vaccination coverage for all state-required vaccines. Median vaccination coverage was 94.3% for 2 doses of measles, mumps, and rubella vaccine; 95.1% for the state-required number of doses of diphtheria and tetanus toxoids and acellular pertussis vaccine; and 93.8% for 2 doses of varicella vaccine.

Recommended Content:

Immunization Healthcare | Vaccine-Preventable Diseases | Vaccine Schedules

Immunization University Certificate Retrieval Instructions

Publication
2/14/2018

This document provides instructions for students to retrieve their certificates for Immunization University courses

Recommended Content:

Immunization Healthcare

National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2016

Report
8/25/2017

CDC provides up-to-date estimated immunization rates among teens using the latest recommended immunization schedules.

Recommended Content:

Immunization Healthcare | Vaccine Schedules | Vaccine-Preventable Diseases

DoDEA Immunization Requirements School Year 2017-18

Publication
5/26/2017

Students who enroll in Department of Defense Education Activity (DoDEA) schools are required to meet specific immunization requirements.

Recommended Content:

Immunization Healthcare | Vaccine Schedules

Surveillance of Vaccination Coverage Among Adult Populations — United States, 2015

Report
5/10/2017

The findings provided in this report indicate that vaccination coverage levels among U.S. adults are not optimal. Improvement in adult vaccination is needed to reduce the health consequences of vaccine-preventable diseases among adults.

Recommended Content:

Immunization Healthcare | Vaccine-Preventable Diseases | Vaccine Recommendations

CDC Pink Book Supplement 2017

Publication
2/22/2017

Epidemiology and Prevention of Vaccine-Preventable Diseases - 13th Edition - Supplement

Recommended Content:

Immunization Healthcare

MMQC-16-1861 New Website URL

Publication
8/8/2016

Recommended Content:

Immunization Healthcare

A human vaccine for the Zika virus may be coming soon

Video
7/22/2016
Scientists at the Walter Reed Army Institute of Research in Silver Spring, Maryland, have developed a vaccine for the Zika virus. They received a strain of the virus from Puerto Rico in November 2015, and have since created a purified inactivated virus, like the flu shot. The vaccine is called ZPIV, and so far, it looks promising that military medical research will be a key contributor to preventing the continued spread of the Zika virus.

Scientists at the Walter Reed Army Institute of Research in Silver Spring, Maryland, have developed a possible vaccine for the Zika virus.

Recommended Content:

Mosquito-Borne Illnesses | Zika Virus | Immunization Healthcare | Medical Research and Development | Bug-Borne Illnesses

Armed Services Blood Program Immunization List

Publication
3/24/2014

Armed Services Blood Program guidance on donor deferral (if any) after receiving immunizations.

Recommended Content:

Vaccine-Preventable Diseases | Vaccine Schedules | Immunization Healthcare

Immunizations and Chemoprophylaxis for the Prevention of Infectious Diseases

Policy
  • Identification #: Army Regulation 40–562 BUMEDINST 6230.15B AFI 48–110_IP CG COMDTINST M6230.4G
  • Date: 10/7/2013
  • Type: Instructions
  • Topics: Immunization Healthcare

Guidance on Medications for Prophylaxis of Malaria 13-002

Policy

This document provides guidance and best practices for the chemoprophylaxis (use of medication to prevent malaria) of Service members serving in malaria endemic regions.

<< < ... 41 42 43 > >> 
Showing results 601 - 615 Page 41 of 43

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.